Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Impact of arterial stiffness on variables of Watch-PAT in patients with obstructive sleep apnea. Source: International Congress 2017 – Diagnostic approaches to obstructive sleep apnoea Year: 2017
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005
A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013
Independent association between obstructive sleep apnea severity and liver stiffness Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Vascular reactivity in patients with mild-moderate obstructive sleep apnoea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Can obstructive sleep apnea (OSA) affect the evolution of pulmonary fibrosis? A description of cases Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Short term hypoxia reduces arterial stiffness in subjects with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 37s Year: 2005
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Pathophysiology of obstructive sleep apnoea: from clinical closing pressure to ventilatory Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more Year: 2019
Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease? Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011